stars 1 stars 2 stars 3

Chimera's mission is to reprogram life to end cancer, using therapies that restore dignity to patients. We do this with next generation, safer and more potent, CAR T therapeutics.

Website http://www.chimera.bio
Employees 4 (2 on RocketReach)
Founded 2015
Address 329 Oyster Point Blvd 300, South San Francisco, California 94080, US
Phone +1 310-497-0736
Technologies
Industry Biotechnology Research, Bioinformatics, CAR T cell therapeutics, Biotechnology, Drug Responsive Control Systems, Data and Analytics, RNA engineering / biology, Science and Engineering, Cellular Immunotherapy, Genetics, Ribozymes, Health Care
Keywords Car T Cell Therapy, Cancer Immunotherapy, Cell Therapy Development, Oncology Therapeutics, Precision Oncology, Immuno-Oncology, Cellular Immunotherapy, Immunotherapy Research, Gene Therapy, Targeted Therapy, Cancer Treatment, Advanced Therapies, Cancer Research, Clinical Trials, Drug Development, Regenerative Medicine, Pharmaceutical Research, Bioengineering, Biotechnology
Competitors Evonik, Twist Bioscience, Codexis, Inc., Amyris, LanzaTech, Precigen, Geno, Zymergen, Inc., Arzeda, Bolt Threads +39 more (view full list)

Chimera Bioengineering Questions

Vlad Hogenhuis is the CEO of Chimera Bioengineering.

2 people are employed at Chimera Bioengineering.

Chimera Bioengineering is based in South San Francisco, California.

Top Chimera Bioengineering Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users